UNLABELLED
Clinical radionuclide therapy studies are commonly preceded by studies with small animals. Reliable evaluation of therapeutic efficacy must be based on accurate dosimetry. This study was performed to evaluate the influence of the mass of organs, the shape of organs, and the distances between organs on S values for mice.
METHODS
A voxel-based version of a geometric model of a mouse was developed for input in our Monte Carlo program based on EGS4. Simulations were made for each source organ separately to resolve the S values for each organ. For verification purposes, S values were calculated for spheres of different masses and compared with the S values in the MIRDOSE3.1 software and with the S values on the Radiation Dose Assessment Resource Web site. The variation in the mass of the organs was determined from dissected mice. The influence of the shape of an organ was investigated by successive elongation of a sphere into spheroids with a constant mass. The right kidney was moved in the phantom of the mouse to evaluate the effect of organ distances on S values. The absorbed fractions for the mouse model presented here were compared with the results from some previously published models. The radionuclides used were (90)Y, (131)I, (111)In, and (99m)Tc.
RESULTS
The results showed that the organ mass for one animal can differ by up to 33% from the mean mass. If linear interpolation from S value tables is used to obtain an S value for the specific mass of an organ, then the S value can differ by up to 80% from its true value. The corresponding deviation obtained by scaling according to mass is 20%. The shape of an organ was found to be the least important parameter for the S value. The cross-absorbed S value is strongly dependent on the geometry and the emitted radiation. For example, a 9.2-mm movement of the kidney can cause the S value from the liver to the right kidney to decrease to 0.05% of its original value for (90)Y.
CONCLUSION
We conclude that the mass and the shape of organs and their locations relative to each other have considerable effects on mouse dosimetry.
[1]
George Sgouros,et al.
Murine S factors for liver, spleen, and kidney.
,
2003,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2]
Michael G Stabin,et al.
PHYSICAL MODELS AND DOSE FACTORS FOR USE IN INTERNAL DOSE ASSESSMENT
,
2003,
Health physics.
[3]
A J Green,et al.
A Mouse Model for Calculating the Absorbed Beta-Particle Dose from 131I- and 90Y-Labeled Immunoconjugates, Including a Method for Dealing with Heterogeneity in Kidney and Tumor
,
2001,
Radiation research.
[4]
B. Beatty,et al.
A mouse model for calculating cross‐organ beta doses from yttrium‐90‐labeled immunoconjugates
,
1994,
Cancer.
[5]
Thomas F. Budinger,et al.
MIRD primer for absorbed dose calculations
,
1988
.
[6]
M G Stabin,et al.
MIRDOSE: personal computer software for internal dose assessment in nuclear medicine.
,
1996,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7]
B. Beatty,et al.
Application of the cross‐organ beta dose method for tissue dosimetry in tumor‐bearing mice treated with a 90y‐labeled immunoconjugate
,
1994,
Cancer.
[8]
Margaret J. Cook,et al.
The anatomy of the laboratory mouse
,
1965
.